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Abstract
Background:  Although tuberculosis is not uncommon among patients with myelodysplastic
syndrome (MDS), only a few reports of such patients suffering from miliary tuberculosis (MT) exist.
MT often presents as a fever of unknown origin and it is a curable disease, yet fatal if left untreated.
Case presentation: W e  r e p o r t  a  c a s e  o f  M T  w i t h  n o  c l inical or laboratory indications of
pulmonary involvement in a patient with MDS, and review the relevant literature. Mycobacterium
tuberculosis was isolated from the liquid culture of a bone marrow aspirate.
Conclusion: Even if the initial diagnostic investigation for a fever of obscure etiology is negative,
MT should not be excluded from the differential diagnosis list. Since it is a curable disease,
persistent and vigorous diagnostic efforts are warranted. In suspected cases, mycobacterial blood
cultures should be collected as soon as possible after hospital admission and early bone marrow
aspirate with mycobacterial cultures is advocated.
Introduction
The increase in numbers and survival of immunocompro-
mised individuals has contributed to the re-emergence of
tuberculosis (TB) as a major public health problem. TB is
common among patients with myelodysplastic syndrome
(MDS) but only a few reports of such patients suffering
from miliary tuberculosis (MT) exist. MT often presents as
a fever of unknown origin (FUO). It is a curable disease,
yet fatal if left untreated and therefore prompt diagnosis is
mandatory.
Case presentation
A 64-year-old male with refractory anemia with multilin-
eage dysplasia and ringed sideroblasts, was admitted with
low grade fever, fatigue and insomnia of three months
duration. He was initially diagnosed with MDS five years
ago, having a single cytogenetic abnormality of trisomy
19. He was treated with recombinant human erythropoi-
etin and pyridoxine. One year prior to admission he
underwent a splenectomy for hypersplenism. Afterwards
his hematological parameters improved and he was only
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occasionally transfused with packed red cells. On admis-
sion physical examination revealed low-grade fever
(37.5°C) and pallor of the skin. He had normochromic
normocytic anemia (hemoglobin 9.8 g/dL), thrombocy-
topenia (79,000/μL) and a normal white blood count
(9,800/μL) with dysplastic neutrophils and mild lympho-
penia (1,400/μL). Biochemistry was normal, ESR was 44
mm/h and CRP was 0.75 mg/dl. Chest radiography, urine
and blood cultures for common bacteria were negative. A
bone marrow aspirate was performed, which revealed a
hypercellular bone marrow with multilineage dysplasia,
24% ringed sideroblasts, 2% blasts and no additional
cytogenetic abnormalities. Bone marrow trephine biopsy
showed areas of hypercellularity without the presence of
epithelioid cell granulomas or areas of necrosis. The aspi-
rate was further cultured for mycobacteria. It was inocu-
lated into MB/Bact Blood Culture Bottles for BacT/Alert
3D (bioMerieux, Durham, NC, USA) and Lowenstein-
Jensen (LJ) slants (bioMerieux, Marcy l' Etoile, France)
and incubated at 37°C. The acid-fast staining of the spec-
imen was positive. The liquid culture turned positive eight
days later. The isolate was identified as a member of the
M. tuberculosis complex with gene probes [AccuProbe
(GenProbe, San-Diego, USA)] and further differentiated
as M. tuberculosis with biochemical analysis. Mycobacte-
rial sputum cultures were negative. The chest computed
tomography (CT) scan was normal. Drug susceptibilities
were determined with the proportions method. The iso-
late was susceptible to all anti-tuberculosis drugs tested.
The patient received a 4-drug regimen (isoniazid,
rifampicin, ethambutol and pyrazinamide) for six
months, followed by isoniazid and rifampicin for another
three months. He defervesced shortly after the onset of
treatment.
Discussion
The term "Miliary Tuberculosis" refers to all types of pro-
gressive disseminated hematogenous TB regardless of the
pathological picture [1]. Its incidence is estimated at
approximately 1% of all TB cases [2] and it is usually diag-
nosed when miliary infiltrates are found either on chest
roentgenograms and CT scans or when there are autopsy
or biopsy findings of miliary organ involvement [1].
However, in some cases such findings may not be evident
in the radiological studies and the term "Disseminated
Tuberculosis" has been proposed for such, whereas the
term "Miliary Tuberculosis" is mostly reserved for cases of
disseminated TB with miliary shadows [3].
MDS is a group of clonal myeloid disorders that often
progress to acute leukemia [4]. Pancytopenia is a common
finding. Cell-mediated immunity is seriously impaired
and patients are predisposed to infections, which account
for about one third of deaths. In a 10-year review from a
comprehensive cancer center, the MDS cases with TB rep-
resented 10.5% of the total number of patients diagnosed
with TB and hematological malignancies [5]. MT was
reported in 3% of the cases of TB with malignancy. How-
ever, there was no report on whether MDS patients were
included in this percentage. In a recent report regarding
patients with hematological malignancies and TB, 7.2%
of them suffered from MDS, but none of the TB cases was
reported as miliary [6]. The authors commented that MT
was considered as rare in the population studied. In
another study, the frequency of TB among MDS patients
was found to be 7.7% [7]. Among those cases only one
was reported as miliary according to the radiological pat-
tern, but with no extrapulmonary involvement. Despite
this relatively high frequency of TB among MDS patients,
only two cases of extrapulmonary tuberculous infections
in this population have been reported. The first was a
localized tuberculous lymphadenopathy [4], whereas the
second was a case of MT in a patient later diagnosed with
MDS [8].
MT is a serious illness demanding timely response. Fever
is a constant symptom and may take the form of FUO [1].
Other symptoms include malaise, anorexia, weight loss,
night sweats, cough, headaches or abdominal pain. In one
third of patients, hepatomegaly or splenomegaly can be
found [1]. Hematological abnormalities such as chronic
disease anemia, leucopenia with lymphopenia, thrombo-
cytopenia or, more rarely, pancytopenia, are frequently
described [1,8,9]. It has been suggested that if MT coexists
with pancytopenia, the latter may reflect an underlying
hematological disease (often leukemia or a preleukemic
disorder) [9]. Chest X-ray or CT images may or may not
reveal miliary infiltrates, as such lesions need weeks to
develop or may not develop at all [1]. In most cases gran-
ulomas can be histologically demonstrated in the tissues
(lung, liver, lymph node or bone marrow) [10].
Isolation of the mycobacterium provides a definite diag-
nosis of MT. The use of liquid media cultures has allowed
the isolation of M. tuberculosis and the determination of its
susceptibilities within days. The yield of acid-fast smears
is usually low in the investigation of FUO [11,12]. TB is
considered to be one of the most common infectious
causes of FUO, with high mortality rates [1,9,12], so early
diagnosis and treatment is important.
One question raised is whether a physician should per-
form an early bone marrow aspirate or whether blood cul-
tures are sufficient for the isolation of mycobacteria in
probable disseminated cases. In a recent study evaluating
the diagnostic yield of blood and bone marrow cultures,
it was suggested that disease caused by members of the M.
tuberculosis  complex could be misdiagnosed without a
bone marrow culture [13]. The combined use of blood
and bone marrow cultures can provide maximum sensi-Publish with BioMed Central    and   every 
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tivity for the diagnosis of disseminated mycobacterial
infections. If mycobacterial infection is suspected, blood
cultures should be collected as soon as possible after hos-
pital admission as they are usually negative when col-
lected later [14].
It is important to emphasize that the forms of TB that
most often cause FUO are either the disseminated form
without the characteristic miliary pattern or extrapulmo-
nary TB without clear localized features [10]. Physicians
usually include TB in their differential diagnosis list when
taking care of patients with a prolonged fever of obscure
origin. However, in the absence of typical chest X-ray data,
and as the initial specimen (usually sputum) acid-fast
staining is negative and the clinical manifestations are not
specific, TB as an etiology is usually by-passed and the
diagnosis (if any) is delayed.
In conclusion, we have reported a rare case of MT with no
clinical or laboratory indications of pulmonary involve-
ment in a patient with MDS. Even if the initial diagnostic
investigation for fever of obscure origin is negative, MT
should not be excluded from the differential diagnosis
list. As MT is a treatable disease, persistent and vigorous
diagnostic efforts are warranted. In suspected cases, myco-
bacterial blood cultures should be collected as soon as
possible after hospital admission and an early bone mar-
row aspirate with mycobacterial cultures is advocated.
Conclusion
￿ Even if the initial diagnostic investigation for fever of
obscure etiology is negative, miliary tuberculosis (MT)
should not be excluded from the differential diagnosis
list.
￿ MT is a curable disease, thus persistent and vigorous
diagnostic efforts are warranted.
￿ In suspected cases, mycobacterial blood cultures should
be collected as soon as possible after hospital admission
and early bone marrow aspirate with mycobacterial cul-
tures should be performed.
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